Replimune (REPL) Gains from Investment Securities (2017 - 2025)
Replimune's (REPL) quarterly Gains from Investment Securities came in at $195000.0 in Q4 2025, up 213.37% year-on-year from $62226.3 in Q4 2024, and up 10.17% quarter-over-quarter from $177000.0 in Q3 2025.
Replimune (REPL) Gains from Investment Securities (2017 - 2025) Analysis & Trends
Replimune has disclosed Gains from Investment Securities across 9 years of filings, most recently posting $195000.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $195000.0, up 213.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (up 1455.24% YoY), and the FY2025 annual result was $1.2 million, up 300.0% from the prior year.
- Gains from Investment Securities came in at $195000.0 for Q4 2025 at Replimune, up from $177000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q1 2025 to a low of -$172000.0 in Q4 2024.
- The 5-year median for Gains from Investment Securities is $132000.0 (2023), against an average of $172875.0.
- Across the five-year window, Gains from Investment Securities jumped 217.57% in 2022 and sank 307.23% in 2024, its largest moves.
- Replimune's Gains from Investment Securities stood at $74000.0 in 2021, then surged by 217.57% to $235000.0 in 2022, then tumbled by 64.68% to $83000.0 in 2023, then tumbled by 307.23% to -$172000.0 in 2024, then surged by 213.37% to $195000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $195000.0 (Q4 2025), $177000.0 (Q3 2025), and $166000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 195,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -172,000.00 |
| Dec 31, 2024 | -172,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 113,000.00 |
| Sep 30, 2023 | 113,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Jun 30, 2023 | 104,000.00 |